What are the key differences in presentation, pathophysiology, patient population, and management between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DKA vs HHS: Key Clinical Differences

Laboratory Distinctions

The most critical laboratory difference is that DKA presents with plasma glucose >250 mg/dL and significant ketoacidosis (pH <7.30), while HHS presents with markedly higher glucose ≥600 mg/dL, minimal ketones, and preserved pH ≥7.30. 1

Glucose and Osmolality

  • DKA: Plasma glucose typically >250 mg/dL 1
  • HHS: Plasma glucose ≥600 mg/dL, often much higher 1, 2
  • HHS: Effective serum osmolality ≥320 mOsm/kg (calculated as 2[Na+ mEq/L] + glucose mg/dL/18), whereas DKA has variable osmolality 1, 2

Acid-Base Status

  • DKA: Arterial pH ranges from <7.00 to 7.30, with serum bicarbonate <10 to 18 mEq/L 1
  • HHS: Arterial pH >7.30, with serum bicarbonate >15 mEq/L 1, 2
  • DKA: Elevated anion gap >10-12 mEq/L due to ketoacid accumulation 1
  • HHS: Variable anion gap 1

Ketone Bodies

  • DKA: Positive serum and urine ketones (ketonemia >3.0 mmol/L) 1, 2
  • HHS: Small or absent ketones in serum and urine (ketonemia ≤3.0 mmol/L) 1, 2

Clinical Presentation Differences

Time Course

  • DKA: Develops rapidly within 24 hours, or even 4-10 hours with insulin pump failure or complete insulin omission 1, 3
  • HHS: Evolves slowly over several days to weeks 1, 2

Symptoms and Signs

Both conditions share polyuria, polydipsia, weight loss, and dehydration, but key differences include:

  • DKA: Kussmaul respirations (deep, rapid breathing), abdominal pain and vomiting common, fruity breath odor 1
  • HHS: More profound dehydration (total body water deficit ~9L vs ~6L in DKA), abdominal pain less common, no Kussmaul respirations 1

Mental Status

  • DKA: Alert to stupor/coma 1
  • HHS: Stupor/coma more frequent and correlates with degree of hyperosmolarity; altered consciousness is more common than in DKA 1, 2

Critical pitfall: Absence of altered mental status does not exclude HHS when metabolic criteria are met 2

Pathophysiology Differences

Both conditions involve insulin deficiency with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone), but the degree differs:

  • DKA: Absolute or severe insulin deficiency leads to uncontrolled lipolysis, releasing free fatty acids that undergo hepatic β-oxidation to produce excess ketone bodies (acetoacetate, β-hydroxybutyrate, acetone), causing metabolic acidosis 1, 3, 4
  • HHS: Residual insulin action is sufficient to prevent significant lipolysis and ketogenesis but inadequate to control hyperglycemia; this explains the minimal ketones despite severe hyperglycemia 1, 4

Patient Population Differences

  • DKA: More common in younger patients with type 1 diabetes; approximately 25% of new type 1 diabetes diagnoses present as DKA 3, 5
  • HHS: Predominantly affects adult and elderly patients with type 2 diabetes, especially those in long-term care facilities who cannot access adequate fluids 1, 5

Precipitating Factors

Common to Both

  • Infection (most common precipitant, accounting for 30-50% of cases) 1, 3
  • Cerebrovascular accident 1
  • Myocardial infarction 1, 3
  • Acute pancreatitis 1
  • Medications: corticosteroids, thiazide diuretics, sympathomimetic agents 1, 3

DKA-Specific

  • Insulin omission or inadequate dosing (most common in established type 1 diabetes, often related to psychosocial issues, financial barriers, or eating disorders) 3
  • SGLT2 inhibitors (now a leading cause, including euglycemic DKA with glucose <200 mg/dL; relative risk 2.46-fold vs placebo) 3
  • Insulin pump failure or disconnection 3

HHS-Specific

  • Elderly patients in chronic care facilities with inadequate fluid access 1
  • Undiagnosed diabetes 1

Management Differences

Fluid Resuscitation

Both conditions require initial isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr during the first hour, but HHS requires more aggressive total fluid replacement. 1

  • DKA: Total body water deficit ~6L, sodium deficit ~100 mEq/kg, potassium deficit ~3-5 mEq/kg 1
  • HHS: Total body water deficit ~9L (100-220 mL/kg), sodium deficit ~100-200 mEq/kg, potassium deficit ~5-15 mEq/kg; aim to correct deficits within 24 hours 1, 2
  • HHS: Limit osmolality reduction to 3-8 mOsm/kg/hr to prevent cerebral edema and central pontine myelinolysis 2

Insulin Therapy

  • DKA: Insulin is the cornerstone of therapy; start immediately with 0.1-0.15 units/kg IV bolus followed by 0.1 units/kg/hr infusion 2, 6
  • HHS: Fluid replacement is the cornerstone of therapy; withhold insulin until glucose stops falling with IV fluids alone (unless ketonemia present), then start 0.15 units/kg bolus followed by 0.1 units/kg/hr 2
  • DKA: Target glucose decline 50-75 mg/dL/hr; add dextrose when glucose reaches 150-200 mg/dL 2
  • HHS: Target glucose decline 50-75 mg/dL/hr; add dextrose when glucose reaches 250-300 mg/dL and maintain at 200-250 mg/dL until resolution 2

Potassium Management

Both require aggressive potassium replacement, but HHS deficits are larger:

  • If K+ <3.3 mEq/L: Hold insulin and give potassium until K+ ≥3.3 mEq/L 2
  • Once renal function confirmed and K+ known: Add 20-30 mEq/L to IV fluids (2/3 KCl, 1/3 KPO₄) 1, 2

Bicarbonate Therapy

  • DKA: May be required if pH <7.0 1
  • HHS: Not recommended (pH typically ≥7.30) 2

Mortality and Prognosis

  • DKA: Mortality ~5% in experienced centers 1
  • HHS: Mortality ~15%, significantly higher than DKA 1, 4
  • Both: Prognosis worsened by extremes of age, coma, hypotension, and hypothermia 1

Critical pitfall: Hypothermia is a poor prognostic indicator and should prompt aggressive evaluation for infection, even though body temperature is unreliable for diagnosing infection in both conditions 1, 3

Mixed Presentations

Up to one-third of patients present with mixed features of both DKA and HHS. 6

  • Mixed cases are managed using the same three-pronged approach: fluids, insulin, and electrolyte replacement 6
  • Tailor therapy according to prominent clinical features 6
  • In adults with mixed features, fluids may be administered more rapidly because cerebral edema risk is low 6
  • In younger patients with mixed features, avoid rapid correction to minimize cerebral edema risk 6

Common Pitfalls to Avoid

  • Failing to identify and treat the precipitating cause (especially infection) is the most common and dangerous pitfall in managing both conditions. 1, 2
  • Do not rely on fever to diagnose infection; patients may be normothermic or hypothermic despite serious infection 1, 3
  • Obtain appropriate cultures (blood, urine, throat) and initiate empiric antibiotics when infection is suspected 1, 2
  • In DKA, abdominal pain may be either cause or consequence; if pain persists after standard therapy, evaluate for intra-abdominal pathology 1
  • Never discontinue basal insulin, even when patient is not eating, as this can precipitate DKA within 4-10 hours 3
  • In HHS, do not add dextrose too early, as this delays correction of hyperosmolarity and prolongs altered mental status 2

References

Guideline

Hyperosmolar Hyperglycemic State (HHS) and Diabetic Ketoacidosis (DKA) Key Differences

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyperosmolar Hyperglycemic State Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diabetic Ketoacidosis Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetic ketoacidosis and hyperosmolar hyperglycemic state.

Medizinische Klinik (Munich, Germany : 1983), 2006

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.